Evidence map›Paper›PMID 39910507›Full record

ArticleBMC public health2025

The triglyceride-glucose index trajectories are associated with cardiovascular diseases in people living with HIV: evidence from a prospective cohort study in China, 2005-2022.

Yinsong Luo, Liqin Sun, Yun He, Fang Zhao, Duo Shan, Fan Bu, Lingyun Ge, Xiaorui Li, Yiyao Hu, Xi Xiao and 2 more

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. [Triglyceride-glucose index changes after one year of antiretroviral therapy].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yinsong Luo *School of Public Health, Shenzhen University Medical School, No. 1066 Xueyuan Avenue, Shenzhen, 518060, China.
Liqin Sun *Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
Yun HeDepartment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
Fang ZhaoDepartment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
Duo ShanNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Fan BuDepartment of Neurology & Psychology, The Fourth Clinical Medical Collegeof, Guangzhou University of Chinese Medicine, Shenzhen, , Guangdong, China.
Lingyun GeSchool of Public Health, Shenzhen University Medical School, No. 1066 Xueyuan Avenue, Shenzhen, 518060, China.
Xiaorui LiSchool of Public Health, Shenzhen University Medical School, No. 1066 Xueyuan Avenue, Shenzhen, 518060, China.
Yiyao HuSchool of Public Health, Shenzhen University Medical School, No. 1066 Xueyuan Avenue, Shenzhen, 518060, China.
Xi XiaoSchool of Public Health, Shenzhen University Medical School, No. 1066 Xueyuan Avenue, Shenzhen, 518060, China.
Hongzhou LuDepartment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China. luhongzhou@fudan.edu.cn.
Jiaye LiuSchool of Public Health, Shenzhen University Medical School, No. 1066 Xueyuan Avenue, Shenzhen, 518060, China. liujiaye1984@163.com.

Funding

Natural Science Foundation of Guangdong Province 2024A1515012118Science and Technology Innovation Committee of Shenzhen Municipality JCYJ20220531102202005Shenzhen Fund for Guangdong Provincial High-level Clinical Key Spcialties SZGSP011Shenzhen High-level Hospital Construction Fund G2022153
6 · The paper itself

Abstract

backgroundThe triglyceride-glucose (TyG) index has been validated as a novel biomarker for cardiovascular disease (CVD) risk. However, the prospective relationship between baseline and long-term trajectories of the TyG index and CVD risk in people living with HIV (PLWH) remains unexplored.

methodsThis cohort study included 16,122 treatment-naive PLWH who initiated antiretroviral therapy (ART) at the Third People's Hospital of Shenzhen from 2005 to 2022. The TyG index was calculated as Ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2]. Group-based trajectory modeling was used to identify distinct TyG index trajectories over the follow-up period. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using multivariate Cox proportional hazards models to assess the association between TyG index trajectories and CVD risk. Nonlinear relationships were investigated using a restricted cubic spline plot.

resultsDuring a median follow-up of 70 months, 214 PLWH developed CVD. Each 1-standard deviation (SD) increase in the baseline TyG index was associated with a 39% higher risk of CVD (HR 1.39, 95% CI 1.22, 1.59) after adjusting for covariates. Participants were categorized into four distinct TyG trajectory groups: low-stable, low-moderate-stable, high-moderate-stable, and high-increasing. After multivariate adjustment, the high-increasing trajectory group had a 2.92-fold (95% CI 1.68, 5.05) increased risk of CVD compared to the low-stable group. The restricted cubic spline plot showed an upward trend between the baseline TyG index and the CVD occurrence (P < 0.001), with the threshold at 8.479 for all HIV patients. Significantly positive correlations between the TyG index and CVD were observed both below the TyG threshold with HR 3.38 (95% CI 1.07, 10.68) and above the threshold with HR 1.43 (95% CI 1.07, 1.92) (both P < 0.05). After stratifying by sex, the spline curves in men were nearly identical to those observed in the overall HIV-infected population. While women also demonstrated a nonlinear association with a similar threshold (8.484), the relationship above the threshold was not statistically significant.

conclusionsHigher baseline TyG index levels and the high-increasing trajectory were significantly associated with increased CVD risk in PLWH. These findings underscore the TyG index as a valuable marker for CVD risk assessment in PLWH, particularly in male populations. Incorporating TyG index monitoring into routine clinical assessments could enhance risk stratification and inform tailored prevention strategies. Further studies are needed to validate these findings in other cohorts and to explore their applicability in women.

Indexed as

Blood GlucoseCardiovascular DiseasesHIV InfectionsTriglyceridesAdultBiomarkersChinaFemaleHumansMaleMiddle AgedProspective StudiesBiomarkersBlood GlucoseTriglyceridesCardiovascular diseaseCohort studyHIVIncidenceTriglyceride-glucose index

Identifiers

PMID39910507
PMCPMC11800576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.